BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32410473)

  • 1. GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background.
    Er J; Chao L; Yiwei L; Feng X; Fei Z; Kan W; Ruifei X
    Exp Lung Res; 2020 Sep; 46(7):226-233. PubMed ID: 32410473
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung cancer suppressor gene GPRC5A mediates p53 activity in non‑small cell lung cancer cells in vitro.
    Jin E; Wang W; Fang M; Wang L; Wu K; Zhang Y; Zhang S; Ma S
    Mol Med Rep; 2017 Nov; 16(5):6382-6388. PubMed ID: 28849235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LOC285194 functions as a tumor suppressor by targeting p53 in non-small cell lung cancer.
    Zhou H; Chen A; Shen J; Zhang X; Hou M; Li J; Chen J; Zou H; Zhang Y; Deng Q; She K; Shi X; He J
    Oncol Rep; 2019 Jan; 41(1):15-26. PubMed ID: 30542733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Gprc5a tumor suppressor loss of expression signature is conserved, prevalent, and associated with survival in human lung adenocarcinomas.
    Kadara H; Fujimoto J; Men T; Ye X; Lotan D; Lee JS; Lotan R
    Neoplasia; 2010 Jun; 12(6):499-505. PubMed ID: 20563252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.
    Lin X; Zhong S; Ye X; Liao Y; Yao F; Yang X; Sun B; Zhang J; Li Q; Gao Y; Wang Y; Liu J; Han B; Chin YE; Zhou BP; Deng J
    Mol Cancer; 2014 Oct; 13():233. PubMed ID: 25311788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.
    Fujimoto J; Kadara H; Garcia MM; Kabbout M; Behrens C; Liu DD; Lee JJ; Solis LM; Kim ES; Kalhor N; Moran C; Sharafkhaneh A; Lotan R; Wistuba II
    J Thorac Oncol; 2012 Dec; 7(12):1747-1754. PubMed ID: 23154545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.
    Chen Y; Deng J; Fujimoto J; Kadara H; Men T; Lotan D; Lotan R
    Cancer Res; 2010 Nov; 70(21):8917-26. PubMed ID: 20959490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
    Liu X; Min S; Wu N; Liu H; Wang T; Li W; Shen Y; Zhao C; Wang H; Qian Z; Xu H; Chen Y; Wang X
    Cancer Lett; 2019 Apr; 447():56-65. PubMed ID: 30685413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53.
    Wudu M; Ren H; Hui L; Jiang J; Zhang S; Xu Y; Wang Q; Su H; Jiang X; Dao R; Qiu X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):72. PubMed ID: 30755245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
    Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
    Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development.
    Song H; Sun B; Liao Y; Xu D; Guo W; Wang T; Jing B; Hu M; Li K; Yao F; Deng J
    Int J Cancer; 2019 Feb; 144(4):777-787. PubMed ID: 29992578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.
    Ali A; Bhatti MZ; Shah AS; Duong HQ; Alkreathy HM; Mohammad SF; Khan RA; Ahmad A
    J Biol Chem; 2015 Aug; 290(35):21336-51. PubMed ID: 25911104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
    Jin X; Liu X; Zhang Z; Xu L
    Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer.
    Chi F; Wang Z; Li Y; Chang N
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1908 Overexpression Inhibits Proliferation, Changing Akt Activity and p53 Expression in Hypoxic NSCLC Cells.
    Ma Y; Feng J; Xing X; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Sun L; Ma Z; Kong R
    Oncol Res; 2016; 24(1):9-15. PubMed ID: 27178817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY; Yue P; Hong WK; Lotan R
    Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
    Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
    J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB represses retinoic acid receptor-mediated GPRC5A transactivation in lung epithelial cells to promote neoplasia.
    Song H; Ye X; Liao Y; Zhang S; Xu D; Zhong S; Jing B; Wang T; Sun B; Xu J; Guo W; Li K; Hu M; Kuang Y; Ling J; Zhang T; Wu Y; Du J; Yao F; Chin YE; Wang Q; Zhou BP; Deng J
    JCI Insight; 2023 Jan; 8(1):. PubMed ID: 36413416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A.
    Lu J; Zhou L; Wu B; Duan Y; Sun Y; Gu L; Xu D; Du C
    Exp Cell Res; 2020 Feb; 387(1):111752. PubMed ID: 31805277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.